The researchers say that the observed improvements to patient quality of life highlight the need for controlled trials looking at non-pharmaceutical CBD products, to evaluate if and how they can be used most effectively by people with epilepsy.
The researchers say that their findings demonstrate a need for more targeted studies exploring frequent cannabis use and its effect on cognition in people with HIV.
Two thirds of the participants will be given a combination of temozolomide chemotherapy and Sativex to treat their glioblastomas, while one third will be given temozolomide and a placebo.
The researchers found a significant association between a child’s exposure to second-hand cannabis smoke from a parent and an increased likelihood of catching a viral respiratory infection, including the common cold and bronchiolitis.
Elucidating the neural effects of psychedelics like LSD is helping to advance our understanding of the treatment strategies for a range of mental health illnesses.
A new study has found that environmental factors have little effect on whether hemp exceeds its THC limits. Instead, the researchers say, hot hemp plants are a result of genetics.
The new open-label phase 2a trial will look at the use of an oral formulation of synthetic psilocybin and evaluate its safety and efficacy in a small number of patients with fibromyalgia.